Parkinson Pipeline Project-treatment development database, research, FDA drug approval, PD clinical trials and sponsors, patient involvement

July 10, 2005<
Amgen's GDNF shows signs of effectiveness LA Times, Business Section,
Letter to the Editor
Regarding "Study adds to dispute over drug by Amgen," July 2:

"Amgen spokeswoman Andrea Rothschild stated that the ability of clinical trial participants with Parkinson's disease to perform day-to-day tasks did not improve when treated with GDNF."

Read the entire letter

Kristen Suthers
Founder
GDNF4Parkinson's
Washington

July 10, 2005<Amgen's GDNF shows signs of effectiveness LA Times, Business Section, Letter to the Editor Regarding "Study adds to dispute over drug by Amgen," July 2:

July 10, 2005<
Amgen's GDNF shows signs of effectiveness LA Times, Business Section,
Letter to the Editor
Regarding "Study adds to dispute over drug by Amgen," July 2: